Star Scientific, Inc. CIGX
One of our past picks, CIGX, is enjoying some momentum today as the stock is currently in the midst of a bounce, which has been extended in part by yesterday’s press. The company highlighted a recent study on the effectiveness of anatabine for treating symptoms of Alzhemiers disease. Anatabine is a primary ingredient in Anatabloc(TM), the dietary supplement developed by CIGX subsidiary, Rock Creek Pharmaceutical.
GLEN ALLEN, Va., Oct. 4, 2011 /PRNewswire via COMTEX/ — Star Scientific, Inc. (Nasdaq: CIGX) reports today the publication of the first peer-reviewed article on the in-vitro and in-vivo activity of anatabine in Alzheimer’s Disease. The article is authored by scientists at the Roskamp Institute and is electronically published in the European Journal of Pharmacology (2011 Sept 19). It states that anatabine lowers Alzheimer’s A-beta production in-vitro and in-vivo.
We always like to keep past plays like this on our radar, as today has proven, you never know when a stock that has performed well in the past is going to provide further opportunities.
FBC Holding, Inc. FBCD
FBCD is another past pick that seemed worthy of mention once again today. For those of you who have followed our activity long enough, you may remember that the first time we talked about this play, was at .015 late last April. By mid-may, it had traded up to .11 for a gain of well over 600% \
We’ve kept an eye on it since then, and have noticed that it had bottomed out at around a penny, and is currently up 20% on the day. This is looking like a good time for us to re-assess our opinion of this stock, after having stood on the sidelines for some time.
We urge our readers to take a look at the Opportunist Magazine Wall Street Journal Edition online, if you would like to receive paper copies by mail, fill out the form on this page. The magazine’s October Edition features our repeat play, Dinewise, Inc. DWIS, and our one-time play, Global Entertainment Holdings GBHL.